Internal Medicine Alert (Vol. 38, No. 22) - November 30, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: November 2016

Valid through: November 2019

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Statins Associated with Lower Parkinson’s Risk in Diabetics
  • Changing Gut Microbiota to Prevent Type 2 Diabetes
  • Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection
  • Pharmacology Update: Eteplirsen Injection (Exondys 51)
  • Clinical Briefs: The Importance of Low Uric Acid in Gout Patients; Gabapentin and Pregabalin Effective for Refractory Chronic Pruritus; Does Technology Accelerate Weight Loss?

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases;
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • Identify cost-effective treatment regimens;
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits
  • 2.0 ABIM MOC Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

PHYSICIAN EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City  

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and

Outcomes Manager, Kaiser

Permanente, Oakland, CA

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine
Stanford University

 

William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser

Permanente; Assistant Clinical

Professor of Medicine, University of California, San Francisco

 

Claire Henchcliffe, MD, PhD

Associate Professor
Neurology and Neuroscience
Weill Cornell Medical College

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

Gainesville

 

Atreyi Mukherji, MD, MPH, FRCPC

Private Practice
Integrative Internal Medicine & Infectious Diseases
Stoney Creek
Ontario

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician

Long Island Jewish Medical Center

NS/LIJ Health Care System
New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly, Merck, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of

AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for and serves on the speakers bureau of Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Peer Reviewer Gerald Roberts, MD; Executive Editor Leslie Coplin; and Assistant Editor Jonathan Springston report no financial relationships relevant to this field of study.

 

Drs. Elliott, Chan, Deresinski, and Mukherji report no financial relationships relevant to this field of study.

 

Dr. Henchcliffe reports she is on the speakers bureau and advisory boards for Teva, IMPAX, and ACADIA; is on the advisory board for U.S. World Meds; and is a consultant for Cynapsus and Pfizer.

Copyright 2016, AHC Media. All rights reserved.